Microsoft and Bristol Myers Squibb have partnered to improve early detection of lung cancer using AI-powered radiology tools.
Key Details
- 1The collaboration aims to leverage Microsoft's scalable AI imaging platform and BMS’s oncology expertise.
- 2Focus is on optimizing early detection and care pathways for non-small cell lung cancer patients.
- 3Targeted initiatives include addressing low adherence to follow-up and improving workflows for underserved populations.
- 4Lung cancer claims about 125,000 U.S. lives annually, but early diagnosis via low-dose CT reduces mortality risk.
- 5The partnership seeks to deliver scalable diagnostic tools and efficiency gains for healthcare organizations.
Why It Matters
Early lung cancer detection has a clear impact on patient survival, but screening adherence remains low. Integrating scalable AI radiology platforms with oncology expertise could significantly improve workflows, diagnosis, and patient outcomes, especially for underserved populations.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
UC Irvine Implements AI to Find Lung Cancer Screening Candidates
UC Irvine's radiology department developed an NLP tool to identify patients eligible for lung cancer screening from EHR notes.